Literature DB >> 20839951

Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship.

Timothy C Jenkins1, Allison L Sabel, Ellen E Sarcone, Connie S Price, Philip S Mehler, William J Burman.   

Abstract

BACKGROUND: Although complicated skin and soft-tissue infections (SSTIs) are among the most common infections requiring hospitalization, their clinical spectrum, management, and outcomes have not been well described.
METHODS: We report a cohort of consecutive adult patients hospitalized for SSTI from 1 January through 31 December 2007 at an academic medical center. Cases meeting inclusion criteria were reviewed and classified as cellulitis, cutaneous abscess, or SSTI with additional complicating factors.
RESULTS: In total, 322 patients were included; 66 (20%) had cellulitis, 103 (32%) had cutaneous abscess, and 153 (48%) had SSTI with additional complicating factors. Injection drug use, diabetes mellitus, and alcohol abuse were common comorbidities. Serum inflammatory markers were routinely measured and blood cultures and imaging studies were routinely performed in each group. Of 150 patients with a positive culture result for an abscess, deep tissue, or blood, Staphylococcus aureus or streptococci were identified in 145 (97%). Use of antibiotics with broad aerobic gram-negative activity (61%-80% of patients) or anaerobic activity (73%-83% of patients) was frequent in each group. The median duration of therapy for cellulitis, cutaneous abscess, and SSTI with additional complicating factors was 13 (interquartile range [IQR], 10-14), 13 (IQR, 10-16), and 14 (IQR, 11-17) days, respectively. Treatment failure, recurrence, or rehospitalization due to SSTI within 30 days occurred in 12.1%, 4.9%, and 9.2% of patients, respectively.
CONCLUSIONS: Hospitalizations for SSTI were common; more than half were due to cellulitis or cutaneous abscess. Frequent use of potentially unnecessary diagnostic studies, broad-spectrum antibiotic therapy, and prolonged treatment courses in these patients suggest targets for antimicrobial stewardship programs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20839951     DOI: 10.1086/656431

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  48 in total

1.  Comparison of the microbiology and antibiotic treatment among diabetic and nondiabetic patients hospitalized for cellulitis or cutaneous abscess.

Authors:  Timothy C Jenkins; Bryan C Knepper; S Jason Moore; Carla C Saveli; Sean W Pawlowski; Daniel M Perlman; Bruce D McCollister; William J Burman
Journal:  J Hosp Med       Date:  2014-09-30       Impact factor: 2.960

2.  Treatment failure definitions for non-purulent skin and soft tissue infections: a systematic review.

Authors:  Krishan Yadav; Avik Nath; Kathryn N Suh; Lindsey Sikora; Debra Eagles
Journal:  Infection       Date:  2019-08-05       Impact factor: 3.553

3.  The antibiotic crisis: can we reverse 65 years of failed stewardship?

Authors:  Brad Spellberg
Journal:  Arch Intern Med       Date:  2011-02-28

4.  Multicenter Study of the Real-World Use of Ceftaroline versus Vancomycin for Acute Bacterial Skin and Skin Structure Infections.

Authors:  T D Trinh; S C J Jorgensen; E J Zasowski; K C Claeys; A M Lagnf; S J Estrada; D J Delaportes; V Huang; K P Klinker; K S Kaye; S L Davis; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

5.  Do Patients with Cellulitis Need to be Hospitalized? A Systematic Review and Meta-analysis of Mortality Rates of Inpatients with Cellulitis.

Authors:  Craig G Gunderson; Benjamin M Cherry; Ann Fisher
Journal:  J Gen Intern Med       Date:  2018-07-18       Impact factor: 5.128

6.  Skin and soft-tissue infections: modern evolution of an ancient problem.

Authors:  Brad Spellberg
Journal:  Clin Infect Dis       Date:  2010-10-15       Impact factor: 9.079

7.  Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO Studies.

Authors:  G Ralph Corey; Jeffery Loutit; Greg Moeck; Matthew Wikler; Michael N Dudley; William O'Riordan
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

8.  Failure of outpatient antibiotics among patients hospitalized for acute bacterial skin infections: What is the clinical relevance?

Authors:  Timothy C Jenkins; Bryan C Knepper; Bruce D McCollister; S Jason Moore; Sean W Pawlowski; Daniel M Perlman; Carla C Saveli; Sean T O'Leary; William J Burman
Journal:  Am J Emerg Med       Date:  2016-02-12       Impact factor: 2.469

Review 9.  Dalbavancin for the treatment of acute bacterial skin and skin structure infections.

Authors:  Sheena Ramdeen; Helen W Boucher
Journal:  Expert Opin Pharmacother       Date:  2015-08-04       Impact factor: 3.889

10.  Avoidable antibiotic exposure for uncomplicated skin and soft tissue infections in the ambulatory care setting.

Authors:  Hermione J Hurley; Bryan C Knepper; Connie S Price; Philip S Mehler; William J Burman; Timothy C Jenkins
Journal:  Am J Med       Date:  2013-12       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.